MA23154A1 - Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie. - Google Patents

Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie.

Info

Publication number
MA23154A1
MA23154A1 MA23459A MA23459A MA23154A1 MA 23154 A1 MA23154 A1 MA 23154A1 MA 23459 A MA23459 A MA 23459A MA 23459 A MA23459 A MA 23459A MA 23154 A1 MA23154 A1 MA 23154A1
Authority
MA
Morocco
Prior art keywords
phenyl
useful
thepapia
pyridineethanamide
salt
Prior art date
Application number
MA23459A
Other languages
English (en)
Inventor
John Murray Robert
Balestria Michael
Mathisen Donald
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1993/000689 external-priority patent/WO1993020052A1/fr
Application filed by Astra Ab filed Critical Astra Ab
Publication of MA23154A1 publication Critical patent/MA23154A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA23459A 1993-04-01 1994-04-01 Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie. MA23154A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB1993/000689 WO1993020052A1 (fr) 1992-04-03 1993-04-01 1-phenyl-2-(2-pyridinyl)ethylamine enantiomere pour le traitement de maladies de degenerescence du systeme nerveux
GB939320273A GB9320273D0 (en) 1993-04-01 1993-10-01 Compound useful in therapy

Publications (1)

Publication Number Publication Date
MA23154A1 true MA23154A1 (fr) 1994-12-31

Family

ID=26302299

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23459A MA23154A1 (fr) 1993-04-01 1994-04-01 Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie.

Country Status (19)

Country Link
EP (1) EP0691957B1 (fr)
JP (1) JP3023987B2 (fr)
CN (1) CN1047168C (fr)
AT (1) ATE156813T1 (fr)
AU (1) AU682348B2 (fr)
CA (1) CA2159478C (fr)
DE (1) DE69404974T2 (fr)
DK (1) DK0691957T3 (fr)
DZ (1) DZ1765A1 (fr)
ES (1) ES2105672T3 (fr)
FI (1) FI109018B (fr)
GB (1) GB9320273D0 (fr)
GR (1) GR3025081T3 (fr)
IL (1) IL109108A (fr)
MA (1) MA23154A1 (fr)
NO (1) NO304647B1 (fr)
PH (1) PH30950A (fr)
SG (1) SG48204A1 (fr)
WO (1) WO1994022831A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135206T1 (de) * 1988-08-12 1996-03-15 Astra Ab Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SE9901340D0 (sv) * 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
SE9901338D0 (sv) * 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
DE10301650A1 (de) * 2003-01-17 2004-07-29 Johannes-Gutenberg-Universität Mainz Medizinisch nützliche 1-Phenyl-2-aminomethylnaphthaline, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung
EP2391606A4 (fr) 2008-12-24 2012-06-13 Astrazeneca Ab Composés d'éthanamine et leur application pour le traitement de la dépression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422191A (en) * 1965-01-21 1969-01-14 Synergistics Inc Compositions and methods for tranquilization employing salts of n-morpholine ethanol
WO1993020052A1 (fr) * 1992-04-03 1993-10-14 Fisons Corporation 1-phenyl-2-(2-pyridinyl)ethylamine enantiomere pour le traitement de maladies de degenerescence du systeme nerveux
ATE135206T1 (de) * 1988-08-12 1996-03-15 Astra Ab Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung
JP2514855B2 (ja) * 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩

Also Published As

Publication number Publication date
NO953846L (no) 1995-11-21
GR3025081T3 (en) 1998-01-30
CA2159478A1 (fr) 1994-10-13
AU6380294A (en) 1994-10-24
ATE156813T1 (de) 1997-08-15
WO1994022831A1 (fr) 1994-10-13
DE69404974T2 (de) 1997-12-18
FI109018B (fi) 2002-05-15
GB9320273D0 (en) 1993-11-17
DK0691957T3 (da) 1997-10-27
CA2159478C (fr) 2005-01-25
CN1047168C (zh) 1999-12-08
EP0691957A1 (fr) 1996-01-17
JPH08508292A (ja) 1996-09-03
EP0691957B1 (fr) 1997-08-13
AU682348B2 (en) 1997-10-02
CN1098095A (zh) 1995-02-01
IL109108A (en) 1999-01-26
SG48204A1 (en) 1998-04-17
DE69404974D1 (de) 1997-09-18
IL109108A0 (en) 1994-06-24
FI954645A0 (fi) 1995-09-29
PH30950A (en) 1997-12-23
DZ1765A1 (fr) 2002-02-17
NO953846D0 (no) 1995-09-28
NO304647B1 (no) 1999-01-25
ES2105672T3 (es) 1997-10-16
FI954645A (fi) 1995-11-29
JP3023987B2 (ja) 2000-03-21

Similar Documents

Publication Publication Date Title
FR2704743B1 (fr) Dispositif pour réduire la sensation de douleur.
TR28718A (tr) Dinamik takilan tipte cocuk bezi.
EP0634189A3 (fr) Appareil générant des ondes ultrasoniques de guérison.
DE69428892T2 (de) Micropartikel verwendbar als ultraschallkontrastmittel
MA23154A1 (fr) Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie.
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
FR2707171B1 (fr) Pellicule adhésive pour bandage et bandage adhésif utilisant cette pellicule.
IS4569A (is) Bensamíð til að meðhöndla taugahrörnunarsjúkdóma
DE69607180D1 (de) Verarbeitung von flüssigkeiten
FR2711054B1 (fr) Ecran de douche pour baignoire et receveur de douche.
ITRM940140A0 (it) Procedimento e dispositivo per la produzione di potassa.
FR2691359B1 (fr) Nouvelle application therapeutique du malate de 1-citrulline.
FR2708191B1 (fr) Appareil de thérapie pour le traitement au moyen d'ondes acoustiques.
NO953847D0 (no) (5)-alfafenyl-2-pyridinetanaminbenzoat og dets anvendelse som legemiddel
ZA966254B (en) Use of unsubstituted and substituted n-(pyrrol-1-y)pyridinamines as anticonvulsant agents.
FR2689764B1 (fr) Utilisation de dérivés de peptides pour la fabrication de médicaments inhibiteurs des endopeptidases 24.15 et 24.16.
KR970019262U (ko) 사용경과시간을 알리는 컴퓨터
ITMI942453A0 (it) Procedimento per il trattamento di bisolfato di sodio contenente cromo
KR950004439U (ko) 액정표시 장치의 패드
ITRM930021A0 (it) Procedimento di trattamento di lastre di trachite vetusia.
KR950002478U (ko) 티브이 멀티 복합 제품의 사운드 처리장치
KR950001955U (ko) 퍼스널 컴퓨터의 전면 커버 고정 장치
FI941672A0 (fi) Modulaer flerprocesskokare